This article explains how VeriSIM Life is using AI to accelerate pharmaceutical research by simulating human biology to predict drug outcomes faster and more accurately. Their AI platform, BIOiSIM, aims to streamline drug development, reducing costs and improving success rates.
“We combined the knowledge from chemistry, physiology, the different types of animals that are being used in testing, and codified all that, and then the different types of patients-based ‘omics’ data — so think genomics, proteomics and such — and distill it all down into a score, which is called the Translational Index. It’s inspired by a credit score.”
Discover more here.